IVR researchers recently published an article presenting the development and evaluation of a gene therapy vector for RPGR, the 3rd most common cause of all inherited retinal disease.
May 20th, 2019Development of a Gene Therapy Vector for the Treatment of RPGR-associated X-linked Retinitis Pigmentosa
May 6th, 2019
A group of IVR researchers have published the first single-cell investigation of central macula versus peripheral retina, from three human donors.
April 5th, 2019
A team of IVR researchers published their successful correction of disease-causing mutations in patient-derived induced pluripotent stem cells (iPSCs). Enhanced S-cone syndrome (ESCS) is caused by recessive mutations in the photoreceptor cell transcription factor NR2E3.